Advocacy Spotlight: Sorting Out Priorities Ovarian cancer survivor and research advocate Annie Ellis is teaming up with researchers to better equip patients with recurrent cancer to make treatment decisions. by Cici Zhang Forward Look Little Consensus on Ovarian Cancer Monitoring Tests and scans may be overused. by Kate Yandell Survivor Profile Going Full Bore Susan Leighton, a 19-year survivor, is a powerful advocate for ovarian cancer research. Her advocacy, which began locally in northern Alabama, has reached the National Cancer Institute and the Department of Defense. by Sue Rochman Forward Look Identifying Ovarian Cancer Risk Study may help spotlight women who would benefit from risk reduction strategies. by Carrie Printz Healthy Habits A Cup of Tea? Black tea consumption may be associated with a reduced risk of ovarian cancer. by Kurt Ullman First Person Never Alone: A Family Journey A mother and daughter exchange thoughts about their “full-family experience” facing an ovarian cancer diagnosis and treatment. by Mary (Dicey) Jackson Scroggins and Nneka Scroggins Survivor Profile Regaining Her Balance Gymnast Shannon Miller's focus and agility helped her capture seven Olympic medals before she was 20. But the most decorated U.S. gymnast in history struggled to overcome the shock of her ovarian cancer diagnosis and treatment. by Kevin Begos Yesterday & Today From Desire to Daisy Whether it was a star turn playing Blanche DuBois or Daisy Werthan, Jessica Tandy sparkled in a tough role. That didn't change after her cancer diagnosis. by Karen Patterson Q&A Writing Through It In a new book and on her New York Times blog, author Susan Gubar chronicles her experiences living with metastatic cancer. by Marci A. Landsmann Survivor Profile Patients’ Rights Powerhouse Myra Christopher wages a personal battle with a rare cancer while continuing to passionately advocate for patients. by Charlotte Huff Cancer Talk October 12: The Week in Cancer News A study sheds light on the difficulty patients have in accessing their medical records, and the U.S. Food and Drug Administration expands approval of the human papillomavirus vaccine. by Kate Yandell October 5: The Week in Cancer News Cancer immunology researchers are awarded a Nobel Prize, and a seventh immune checkpoint inhibitor is approved by the U.S. Food and Drug Administration. by Kate Yandell Why I Put Down My Camera A professional photographer shares advice on living in the moment after caring for his father, who had stage IV lung cancer. by Jay Perry Vaccinating Against Cancer The human papillomavirus vaccine can significantly cut recipients’ risk of several types of cancer. So why are vaccination rates relatively low in the U.S.? by Brad Jones More Posts